Information Provided By: 
Fly News Breaks for February 24, 2020
SEM
Feb 24, 2020 | 08:20 EDT
RBC Capital analyst Frank Morgan raised his price target on Select Medical to $32 and kept his Outperform rating after its "strong beat" on Q4 earnings. The analyst says that all 4 of the company's segments had top-line growth and margin expansion, while noting that its revenue growth forecast of 2%-4% in FY20 could also prove to be "conservative". Morgan is positive on the company's competitive position and relatively stable operating environment for its LTAC and IRF businesses.
News For SEM From the Last 2 Days
There are no results for your query SEM
